Published Online: January 01, 1970
This supplement to The American Journal of Managed Care provides an overview of the epidemiology and pathophysiology of non-small cell lung cancer (NSCLC) and examines the gene mutations involved in the pathogenesis of NSCLC. Also discussed are the current and emerging treatment strategies for NSCLC, including the utility of biomarker analysis in targeted therapies, as well as the managed care aspects of epidermal growth factor receptor testing in NSCLC, such as its implementation into clinical practice and the evaluation of outcomes for cost-effectiveness.



Recommended Reading

No Result Found